This large unique dataset allowed an in-depth investigation of the impact of the type of mutated gene (BRCA1 vs BRCA2) and hormone receptor status on clinical behavior and outcomes of BRCA-mutated breast cancer in young women. This evidence concerns the gene BRCA2 and breast cancer.